Posts in tag
REGENXBIO
REGENXBIO raises $70.5M in Series D
What does REGENXBIO do? REGENXBIO, is a leading biotech company which develops adeno-associated viral vector based therapeutics and research tools, offering NAV, a recombinant AAV-vectorREGENX Biosciences, LLC, a biopharmaceutical company, develops therapeutics and research tools which are based on adeno associated viral vectors. This company offers a gene delivery technology, NAV, which includes recombinant adeno …